From zerofox.com
The pharmaceutical industry gained significant attention with the outbreak of the coronavirus (COVID-19) crisis. At the onset of the pandemic, demand from the pharmaceutical industry increased due to the need for COVID-19 treatment medication and prevention kits. The pharmaceutical industry endured a major shift in the threat landscape compared to the early stages of the pandemic from March 2020 to September 2021. Advanced Persistent Threat (APT) groups and cyber criminals targeted pharmaceutical companies to steal highly sensitive information, such as drug formulas and COVID-19 research and development data, which are extremely valuable to cyber criminals for financial gain, nation-state-backed actors to support their political agenda, and hacktivists to support their cause of economic or social awareness.